1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Pennsylvania >
  6. Kite Pharma Acquires Interius BioTherapeutics

M&A Deal Summary

Kite Pharma Acquires Interius BioTherapeutics

On August 21, 2025, Kite Pharma acquired life science company Interius BioTherapeutics for 350M USD

Acquisition Highlights
  • This is Kite Pharma’s 4th transaction in the Life Science sector.
  • This is Kite Pharma’s 2nd largest (disclosed) transaction.
  • This is Kite Pharma’s 3rd transaction in the United States.
  • This is Kite Pharma’s 2nd transaction in Pennsylvania.

M&A Deal Summary
Date 2025-08-21
Target Interius BioTherapeutics
Sector Life Science
Buyer(s) Kite Pharma
Deal Type Add-on Acquisition
Deal Value 350M USD
Advisor(s) Evercore Group (Financial)

Target

Interius BioTherapeutics

Philadelphia, Pennsylvania, United States
Interius BioTherapeutics is a clinical-stage biotechnology company engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases in oncology, autoimmunity, and beyond. The Company’s lead programs aim to overcome the current limitations of ex vivo chimeric antigen receptor (CAR) T-cell therapy by creating therapeutic CAR cells directly in the patient’s body. Interius BioTherapeutics is based in Philadelphia, Pennsylvania.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Kite Pharma

Santa Monica, California, United States
Category Company
Founded 2009
Sector Life Science
Employees184
Revenue 22M USD (2016)
DESCRIPTION
Kite Pharma's corporate headquarters in Santa Monica, California.
Kite Pharma's corporate headquarters in Santa Monica, California.

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. Kite Pharma was formed in 2009 and is based in Santa Monica, California.

DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 3 of 3
State: Pennsylvania M&A 2 of 2
Country: United States M&A 3 of 3
Year: 2025 M&A 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-20 Tmunity

Philadelphia, Pennsylvania, United States

Tmunity is a private biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases. Tmunity was founded in 2015 and is based in Philadelphia, Pennsylvania.

Buy -
Mergr

Solution for

Product

Company

Legal